SPOTLIGHT: Ventana inks buyout deal


Ventana Medical Systems, which has been fighting a takeover offer from Roche, has inked a deal to acquire Spring BioScience--which makes rabbit monoclonal antibodies and other reagents--for $28.9 million. Spring investors also stand to gain up to $11.7 million in milestones. Report